Odonate Therapeutics (ODTC)

Odonate Therapeutics (ODTC) is a Shell Companies company in the Financial Services sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $53.4M; returns 1 day +0.0%, 1 week +0.0%, 1 year +0.0%.

Odonate Therapeutics, Inc., now known as Odonate, Inc., was a pharmaceutical company focused on developing therapeutics for cancer treatment. Its primary focus was on tesetaxel, an orally administered chemotherapy agent, in Phase III clinical study for patients with metastatic breast cancer.

Groups ODTC belongs to

• Healthcare
• Pharmaceuticals
• Oncology

ODTC financial model: income statement, cash flow and balance sheet